References
Weiss RB, Christian MC. Drugs 46: 360–377, 1993
Gore M, et al. Br J Cancer 60: 767–769, 1989
Caussanel J-P, et al. J Nat Can Inst 82: 1046–1050, 1990
Gietema JA, et al. Br J Cancer 67: 396–401, 1993
O’Rourke T, et al. Proc Am Soc Clin Oncol 12: 137, 1993
Hamers FPT, et al. Eur J Cancer 27: 372–376, 1991
Lévi F, et al. Cancer 69: 893–900, 1992
Kato T, et al. Gan To Kagaku Ryoho 19: 1285–1293, 1992
Kudelka A, et al. Proc Am Soc Clin Oncol 12: 269, 1993
Harstrick A, et al. Ann Oncol 3 (Suppl. 1): 50, 1992
McKeage MJ, et al. Proc Am Soc Clin Oncol 12: 130, 1993
Anon. Drugs & Therapy Perspectives 1: 13–15, 8 Mar 1993
Perez-Solar R, et al. Cancer Res 50: 4254–4259, 1990
Rights and permissions
About this article
Cite this article
New cisplatin analogues attempt to supersede cisplatin and carboplatin. Drugs Ther. Perspect 3, 7–8 (1994). https://doi.org/10.2165/00042310-199403010-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199403010-00003